Sign in
CompletedNo phase

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder

Key facts

Who runs it
Asad Ullah Jan
Where
Pakistan2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
6 May 2025
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Eye Movement Desensitization and Reprocessing Therapy
  • Selective serotonin reuptake inhibitors
Record updated
7 May 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age 18-60 years
  • Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD)
  • Duration of illness ≥ 6 months
  • Able to provide informed consent

Who cannot take part

  • Concurrent psychotherapy or psychiatric medication (except study-assigned SSRI)
  • History of psychotic disorder or bipolar disorder
  • Current substance abuse or dependence
  • Active suicidal ideation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial aims to compare the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Post-Traumatic Stress Disorder (PTSD). Adult patients diagnosed with PTSD will be randomly assigned to receive either EMDR therapy or SSRIs for a period of six weeks. The primary outcome is the rate of remission as measured by validated PTSD symptom severity scales at Week 6. Secondary outcomes include changes in functional impairment and patient-reported quality of life. The study seeks to determine whether EMDR therapy is a non-pharmacological alternative to SSRIs for achieving symptom remission in PTSD.

The 2 groups in the trial

  • EMDR TherapyTreatment being tested

    Participants will receive Eye Movement Desensitization and Reprocessing (EMDR) therapy over six weeks.

    Treatment: Eye Movement Desensitization and Reprocessing Therapy

  • Selective Serotonin Reuptake Inhibitors (SSRIs)TreatmentExisting treatment, for comparison

    Participants will receive selective serotonin reuptake inhibitors (SSRIs) such as Sertraline over six weeks.

    Treatment: Selective serotonin reuptake inhibitors

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder: A Randomized Controlled Trial
Record updated
7 May 2026